Stratasys Expands TrueDent Dental Solutions into European Market
Stratasys Expands TrueDent Dental Solutions into European Market
Stratasys (NASDAQ: SSYS), a leader in 3D printing solutions, announced a significant milestone with the launch of its TrueDent-D™ resin across Europe. Now recognized as a CE Mark Class I medical device, this development allows for the innovative TrueDent™ monolithic multi-shade digital denture solution to reach dental labs and clinicians in need of advanced denture solutions throughout the region.
Transformative Features of TrueDent
TrueDent's entry into the European market follows a successful introduction in the United States in 2023, positioning it as a game-changing option for the efficient production of dentures. Dental laboratories and practitioners are already expressing strong interest, with over 30 customers expected to engage with the TrueDent-D resin by the first quarter of 2025.
The demand for digital denture solutions is on the rise, translated by a report indicating an increase in the market value for such options in Europe from approximately USD 2.19 billion in 2023 to an estimated USD 2.45 billion by 2028. Stratasys's TrueDent solution is crafted to respond to this demand, offering a fully digital workflow that enables dental labs to produce highly customized dentures efficiently. The cost savings are notable; labs can expect to produce TrueDent dentures at less than half the price of traditional methods. Furthermore, the J5 DentaJet™ printer developed by Stratasys can manufacture over 30 full monolithic, multi-shade dentures in a single print job, setting a new standard in the industry.
The Advantages of Digital Dentures
One standout feature of TrueDent is the expedited ability to print duplicate dentures at the press of a button. This capability allows dental professionals to quickly offer a backup or replacement to patients, hence ensuring continuity of care. Unique to this solution is the ability to produce identical dentures, maintaining essential fit, form, and aesthetics, all of which are crucial for patient satisfaction. These features empower laboratories to explore new business models, scaling production without incurring additional costs or increasing labor demands.
Tra’ Chambers, Owner of Express Dental Laboratories—a leading U.S. adoptee of TrueDent—shared, “The TrueDent solution has transformed our denture business. The streamlined digital workflow and precision allow us to produce up to 225 dental appliances daily while delivering high-fidelity, aesthetically pleasing products. The offering from Stratasys has elevated our capability of care, saving time and costs for both clinicians and patients.” This real-world impact highlights the efficiency and reliability of the TrueDent system.
Addressing Dental Needs in Europe
Edentulism, or the condition of lacking natural teeth, affects millions globally, including a significant percentage over the age of 50. The increase of digital methods in U.S. labs from 5% in 2022 to 11% in 2024 further indicates a growing trend toward digital solutions in denture production. In Europe, dental labs are similarly pivoting towards digital workflows, seeking to solve labor shortages and cater to patient needs with heightened precision and speed.
TrueDent addresses the limitations faced by labs reliant on traditional fabrication methods which often require extensive manual assembly by skilled artisans. In the U.S., TrueDent's implementation is already reshaping the operations of dental laboratories. The introduction of an unattended, streamlined digital workflow decreases manual handling by over 27 touchpoints for each print and shortens chair time for professionals and patients alike, all while enhancing satisfaction with aesthetically pleasing, precisely designed dentures.
Excitement in the Dental Community
“We are ecstatic to introduce TrueDent-D to the European market,” noted Erez Ben Zvi, Vice President of Healthcare at Stratasys. “Our groundbreaking TrueDent solution seamlessly integrates fidelity, aesthetics, and production scalability while reducing labor costs. The anticipation surrounding this innovative offering is palpable, promising to transform the experiences of dental professionals and raise the standards of patient care.”
For further details regarding the TrueDent digital denture application, visit the Stratasys TrueDent page.
Frequently Asked Questions
What is TrueDent-D?
TrueDent-D is a digital denture resin that has been launched by Stratasys in Europe, allowing for the production of monolithic, multi-shade dentures.
Why is TrueDent-D significant for dental labs?
This solution provides a fully digital workflow, enabling dental labs to produce customized dentures more efficiently, which also leads to significant cost savings.
How many dentures can the J5 DentaJet printer produce?
The J5 DentaJet printer can produce over 30 full monolithic, multi-shade dentures in a single print job, which is a notable achievement in the industry.
What impact does edentulism have?
Edentulism affects millions of individuals worldwide, leading to an increasing demand for effective denture solutions to restore oral function and aesthetics.
How is Stratasys transforming dental care?
By introducing innovative technologies like TrueDent-D, Stratasys supports dental labs in overcoming challenges, enhancing patient care, and improving operational efficiencies within the industry.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.